In our study, we found that Mel-18 was lower-expressed in CSC-like spheroid cells and metastatic gastric cancer tissues, and Mel-18 overexpression decreased the number and size of CSC-like cells and inhibited tumorigenicity in vivo, decreased chemo-drug resistance and inhibited cancer cells migration. The gene discussed is PCGF2; the disease is gastric cancer.